PDA Letters (Cards)

Aseptic Transfers to Grade A

By: Julian Petersen, groninger Richard Denk, Skan AG

On The Issue: PDA India Chapter

PDA, Inc.

Points to Consider on Aseptic Filling Technologies Nearing Completion

By: Rebecca Brewer, Quality Executive Partners

Welcome New PDA Germany/Austria/Switzerland Chapter!

By: Julian Petersen, groninger

Intrinsic Sterile Connection Devices

By: William Peterson, Merck

Digitization Advancing in the Near Future

By: Toni Manzano

Nominations for PDA Board of Directors Open to May 8

PDA, Inc.

Legacy Filling Lines Evolve

By: Ahmed Elsaid, Emergent Biosolution Ajay Pazhayattil, PhD, cGMP World

Community News Quarterly

PDA, Inc.

Sponsored by Ecolab

The Pain of Change – Could Suppliers be Part of the Cure?

By: Matt Cokely, Global Technical Consultant, Strategic Director, Ecolab Life Sciences

On The Issue: PDA Training

PDA, Inc.

Building a Quality Culture Using Quality Systems

By: Ron Branning, GXP Quality Systems, LLC

The Annex 1 2022 Revision: A Success Story, Still to be Written

By: Hal Baseman, ValSource, Inc. Gabriele Gori, PDA SAB

The Key to Compliance with Annex 1 and Risk Based Regulations

By: Noelle Clifford, PharmaLex

A View on the Revised Annex 1

By: Antonio Burazer, Takeda Alexander Artau, Sanofi Elisabeth Wagner,  CSL Behring Joseph Straub, Merck

Elevating Sterile Manufacturing

By: Simone Biel, PhD, Merck

The14th Parenteral Packaging Conference

By: Philippe Lauwers, Terumo Pharmaceutical Solutions

Sterility Testing of Cell and Gene Therapies

By: Zachary Beck, Eurofins

On The Issue: The Quality Management Maturity Model

PDA, Inc.

A Comprehensive Review of Regulatory Intelligence: Exploring Tools and Program Maturities

By: Maria Jacobs, PhD, Pfizer, Inc. Katie Bevard, Amgen Jason Kerr, Moderna